TEVA PHARMACEUTICAL INDUSTRIES LTD - 10-Q Filing
Teva Pharmaceutical Industries reports Q3 2026 results including intangible asset impairments and updates on collaborative R&D arrangements.
Tickers: $TEVA
Read the full article at SEC EDGAR
Part of the story Phathom Pharmaceuticals, Inc. - 10-Q Filing (11 articles)